Shu Yu Civilian Pharmacy Corp., Ltd. Class A

Shu Yu Civilian Pharmacy Corp., Ltd. Class A

SSZSE:301017
12.80
CNY
-0.45
(-3.40%)
0.13EPS
215.42P/E
6.02BMarket Cap
May 05Next Earn

Total Valuation

CNY

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A carries a market capitalization of 6.02B, placing it among publicly traded companies globally. Its enterprise value stands at 7.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.02B
Enterprise Value7.68B

Important Dates

Shu Yu Civilian Pharmacy Corp., Ltd. Class A's next confirmed earnings release is scheduled for May 5, 2027.

Earnings Date5/5/2027

Share Statistics

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A has 405.61M shares outstanding.

Shares Outstanding405.61M

Valuation Ratios

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A trades at a trailing price-to-earnings ratio of 215.42. The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 2.87.

PE Ratio215.42
PS Ratio0.53
PB Ratio2.87
P/TBV Ratio-17.20

Enterprise Valuation

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A trades at an EV/EBITDA multiple of 79.59 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.71 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 79.59 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 7.68B versus a market cap of 6.02B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.71
EV / EBITDA79.59
EV / EBIT79.59

Financial Position

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 140.31, indicating elevated leverage, while an interest coverage ratio of 0.74 demonstrates limited ability to service its debt obligations.

Current Ratio0.90
Quick Ratio0.27
Debt / Equity140.31
Debt / EBITDA32.77
Interest Coverage0.74

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A posted a return on equity (ROE) of 1.29, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 0.96 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 0.27, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 1.38, useful for judging operating efficiency across full business cycles. The company generates approximately 681,123.32 in revenue per employee across its workforce of 15,933.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.97 indicates how many times Shu Yu Civilian Pharmacy Corp., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)1.29
Return on Assets (ROA)0.27
Return on Invested Capital (ROIC)0.96
Return on Capital Employed (ROCE)1.38
Revenue Per Employee681,123.32
Employee Count15,933.00
Inventory Turnover3.97

Taxes

CNY

Over the twelve months ended September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A recorded 36.52M in income tax expense. That works out to an effective tax rate of 42.41, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 86.10M, leaving 26.90M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax36.52M
Effective Tax Rate42.41

Stock Price Statistics

CNY

As of the close on November 17, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A's stock has declined approximately 17.84% over the past 52 weeks. The 50-day moving average sits at 13.68, while the 200-day moving average is 14.12.

52-Week Price Change-17.84%
50-Day Moving Average13.68
200-Day Moving Average14.12

Income Statement

CNY

Over the twelve months ended September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A generated 10.85B in revenue and converted that into 26.90M in net income, yielding earnings per share of 0.13. EBITDA reached 96.50M, while operating income came in at 269.17M.

Revenue10.85B
Gross Profit2.85B
Operating Income269.17M
Pretax Income86.10M
Net Income26.90M
EBITDA96.50M
EBIT96.50M
Earnings Per Share (EPS)0.13

Balance Sheet

CNY

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A holds 1.66B in cash and equivalents against 3.16B in total debt, resulting in a net debt position of 712.76M. Total book value stands at 2.10B, with working capital of -620.91M providing operational flexibility.

Cash & Cash Equivalents1.66B
Total Debt3.16B
Net Debt712.76M
Equity (Book Value)2.10B
Book Value Per Share5.18
Working Capital-620.91M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-83.65M

Margins

Over the twelve months ended September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A posted a gross margin of 26.29, reflecting its pricing power and cost economics. The operating margin of 2.48 and net profit margin of 0.25 provide insight into operational efficiency.

Gross Margin26.29
Operating Margin2.48
Pretax Margin0.79
Profit Margin0.25
EBITDA Margin0.89

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A paid dividends of 0.29 per share. The dividend payout ratio of 155.28 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 7.62, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Shu Yu Civilian Pharmacy Corp., Ltd. Class A shareholders.

Dividend Per Share0.29
Payout Ratio155.28
Shareholder Yield7.62

Scores

As of September 30, 2026, Shu Yu Civilian Pharmacy Corp., Ltd. Class A has an Altman Z-Score of 2.12, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.12